- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint said an edoxaban initiation leavepiece omitted hepatic considerations. Panel had concerns but ruled no breach because there was no evidence it…
A post-conference promotional video for Entresto hosted on a learned society website omitted prescribing information and failed to state key initiation limits…
Novartis breached the ABPI Code after a Leqvio webinar registration page displayed the adverse event reporting statement in a position/font size that…
At ESC-HFA 2022, Ferinject banner ads ran for 60 days on the congress site/Medscape and reached UK HCPs unintentionally. UK signatory certification…
Complaint about symposium slides allegedly lacking job codes and a speaker’s ‘mismatch of the vaccine’ comment. PMCPA ruled no breach of Clauses…
Complaint alleged Novo Nordisk funded an obesity practitioner’s salary to induce prescribing and influenced local liraglutide criteria. Panel and Appeal Board found…
Nine MSD UK employees ‘liked’ an NHS England LinkedIn post about pembrolizumab, including “cancer-free” patient story. PMCPA ruled breaches of Clauses 5.1,…
A senior UK employee ‘liked’ an Otsuka US LinkedIn post about unlicensed ulotaront, which the Panel said proactively disseminated promotional claims. Breaches…
Takeda’s HCP-only Rare Disease Hub website was ruled in breach for not displaying the required adverse event reporting statement prominently. Other allegations…
AbbVie admitted an HCP registration webpage went live in a version that differed from the certified copy after an agency uploaded the…
Two UK-based GSK employees ‘liked’ a LinkedIn post about US FDA approval for Jemperli + chemotherapy. Panel ruled this brought the post…
A health professional alleged AstraZeneca’s Fluenz Tetra post-administration booklet omitted two SmPC safety requirements. Panel found the points were covered pre-administration and…
Unapproved social posts and an NHS Trust web article recruiting for Moderna’s NextCOVE trial were found misleading and unclear about Moderna’s involvement.…
Four UK Pfizer employees ‘liked’ a third‑party LinkedIn post naming talazoparib. Panel said the likes proactively disseminated POM info to the public:…
A third‑party medical publication email drove HCPs to a webpage containing Gilead‑sponsored content, but the email didn’t declare Gilead’s involvement upfront. Breach…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.